Research suggests that Phascolarctobacterium may improve obesity, insulin sensitivity, adipose tissue inflammation, and atherosclerosis by beneficially altering gut microbiota composition [55]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.